FDA: ADHD drug use should continue despite study on sudden death

06/16/2009 | Wall Street Journal, The

The FDA said children with attention-deficit/hyperactivity disorder should continue taking medications for their condition because there is no sufficient evidence that the drugs cause sudden death. The warning follows a study partly funded by the agency that cites 10 cases of sudden death in the patient group taking stimulants.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC